Immunotherapy shows promise for rare chest cancers
NCT ID NCT03134118
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study tests the drug nivolumab in 55 people with advanced thymoma or thymic carcinoma that has worsened after initial chemotherapy. The goal is to see if nivolumab can slow cancer growth and how safe it is. Participants receive nivolumab infusions, and researchers track tumor response and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYMIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Academisch Ziekenhuis Maastricht
Maastricht, 6202, Netherlands
-
Assistance Publique - Hopitaux de Marseille - Hopital Nord (APHM)
Marseille, France
-
CHU Toulouse - Hopital Larrey
Toulouse, 31059, France
-
CHU de Brest
Brest, 29200, France
-
CHU de Grenoble - La Tronche - Hôpital A. Michallon
La Tronche, 38700, France
-
CHU de Lyon - Hopital Louis Pradel
Bron, 69500, France
-
Centre Francois Baclesse
Caen, 14076, France
-
Erasmus MC
Rotterdam, Netherlands
-
Gustave Roussy
Villejuif, 94805, France
-
Hospital Universitario 12 De Octubre
Madrid, Spain
-
Institut Curie- Hopital de Paris
Paris, 75248, France
-
Institut Jules Bordet
Brussels, Belgium
-
NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital
Glasgow, United Kingdom
-
Royal Marsden Hospital - Chelsea, London
London, United Kingdom
-
Royal Marsden Hospital - Sutton, Surrey
Sutton, United Kingdom
-
The Christie NHS Foundation Trust
Wythenshawe, M23 9LT, United Kingdom
-
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis
Amsterdam, 1066, Netherlands
-
UniversitaetsSpital Zurich
Zurich, Switzerland
-
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, Belgium
-
Vall d'Hebron Institut d'Oncologia
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.